In 1853 was created University of Melbourne, which is appeared as Corporate Investor. The main department of described Corporate Investor is located in the Melbourne. The company was established in Australia.
The usual things for fund are deals in the range of 1 - 5 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2016.
Among the various public portfolio startups of the fund, we may underline Clarity Pharmaceuticals We can highlight the next thriving fund investment areas, such as Health Care, Software. For fund there is a match between the location of its establishment and the land of its numerous investments - Australia. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 2-3 participants. Despite the University of Melbourne, startups are often financed by Sydney Angels. The meaningful sponsors for the fund in investment in the same round are Cicada Innovations, Australian Nuclear Science and Technology Organization, ATP Innovations. In the next rounds fund is usually obtained by Singtel Innov8, Melbourne Accelerator Program, Adventure Capital.
The current fund was established by Paul Gregorevic, PhD.
| Fund Name | Location |
| Crane Venture Partners | England, London, United Kingdom |
| Future Planet Capital | England, London, United Kingdom |
| Global Excel Management Inc. | Canada, Quebec, Sherbrooke |
| Invitation Homes | Dallas, Texas, United States |
| Madison Paige Capital | New York, New York, United States |
| NKB | Baden-Wurttemberg, Binswangen, Germany |
| RCGI | - |
| Richard Rainwater | Fort Worth, Texas, United States |
| River Valley Investors | Massachusetts, Springfield, United States |
| Signet Enterprises | Akron, Ohio, United States |
| Stuart Mill Venture Partners | Falls Church, United States, Virginia |
| Student Transportation Inc. | Barrie, Canada, Ontario |
| Swicorp | Ar Riyad, Riyadh, Saudi Arabia |
| The Edgewater Group | Jersey City, New Jersey, United States |
| The Hive | California, Palo Alto, United States |
| Venesio family | - |
| Xidihui Zichan | China, Fujian, Xiamen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Apromore | $15M | 06 Aug 2024 | Parkville, New South Wales, Australia | ||
The Leaf Protein Company | $620K | 12 Jun 2024 | Adelaide, South Australia, Australia | ||
Psychae Therapeutics | $3M | 12 Nov 2023 | Carlton, Victoria, Australia | ||
Kali Healthcare | $500K | 08 Mar 2023 | Melbourne, Victoria, Australia | ||
Synchron | $75M | 16 Dec 2022 | Gandhinagar, Gujarat, India | ||
Synchron | $75M | 15 Dec 2022 | California, United States | ||
Tiny Bright Things | $1M | 03 Nov 2022 | Melbourne, Victoria, Australia | ||
AIBUILD | $18K | 24 Nov 2021 | Melbourne, Victoria, Australia | ||
Synchron | $40M | 03 Jun 2021 | California, United States |
– Synchron, a New York-based company developer of brain interface platforms, raised $40M in series B funding.
– The round was led by Khosla Ventures with participation from Forepont Capital Partners, ID8 Investments, Shanda Group, General Advance, Subversive Capital (Michael Auerbach), re.Mind Capital (Christian Angermayer), as well as individuals Arani Bose (Penumbra) and Thomas Reardon and existing investors NeuroTechnology Investors, METIS innovative, and the University of Melbourne.
– The company intends to use the funds to launch U.S. clinical trials of minimally invasive brain computer interface following the conduction of human trials in Australia.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Apromore | $15M | 06 Aug 2024 | Parkville, New South Wales, Australia | ||
The Leaf Protein Company | $620K | 12 Jun 2024 | Adelaide, South Australia, Australia | ||
Psychae Therapeutics | $3M | 12 Nov 2023 | Carlton, Victoria, Australia | ||
Kali Healthcare | $500K | 08 Mar 2023 | Melbourne, Victoria, Australia | ||
Synchron | $75M | 16 Dec 2022 | Gandhinagar, Gujarat, India | ||
Synchron | $75M | 15 Dec 2022 | California, United States | ||
Tiny Bright Things | $1M | 03 Nov 2022 | Melbourne, Victoria, Australia | ||
AIBUILD | $18K | 24 Nov 2021 | Melbourne, Victoria, Australia | ||
Synchron | $40M | 03 Jun 2021 | California, United States |
